Dyne Therapeutics, Inc.
DYN· Nasdaq
Dyne Therapeutics, Inc.
- Last sale
- Oct 1, 2026 · -1.83%
- Market cap
- $2.95B
- 186.75M shares
- Filings
- 792
Price
Oct 1, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Research And Development
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $398,333,000 | reported | |
| FY 2024 | 2024-12-31 | $281,406,000 | reported | |
| FY 2023 | 2023-12-31 | $210,762,000 | reported | |
| FY 2022 | 2022-12-31 | $142,760,000 | reported | |
| FY 2021 | 2021-12-31 | $121,308,000 | reported | |
| FY 2020 | 2020-12-31 | $45,200,000 | reported | |
| FY 2019 | 2019-12-31 | $11,040,000 | reported |
Dyne Therapeutics, Inc. · CIK 1818794 · Engraved from SEC EDGAR
